Thrivent Financial for Lutherans’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $929K | Buy |
28,119
+449
| +2% | +$14.8K | ﹤0.01% | 1826 |
|
|
2025
Q1 | $1.11M | Sell |
27,670
-98
| -0.4% | -$3.94K | ﹤0.01% | 1642 |
|
|
2024
Q4 | $1.31M | Buy |
27,768
+126
| +0.5% | +$5.93K | ﹤0.01% | 1725 |
|
|
2024
Q3 | $1.46M | Sell |
27,642
-62
| -0.2% | -$3.28K | ﹤0.01% | 1668 |
|
|
2024
Q2 | $1.5M | Buy |
27,704
+3,132
| +13% | +$170K | ﹤0.01% | 1584 |
|
|
2024
Q1 | $1.72M | Sell |
24,572
-62,802
| -72% | -$4.4M | ﹤0.01% | 1524 |
|
|
2023
Q4 | $7.3M | Sell |
87,374
-445
| -0.5% | -$37.2K | 0.02% | 729 |
|
|
2023
Q3 | $2.59M | Sell |
87,819
-3,674
| -4% | -$108K | 0.01% | 1129 |
|
|
2023
Q2 | $2.98M | Sell |
91,493
-2,288
| -2% | -$74.6K | 0.01% | 1086 |
|
|
2023
Q1 | $3.3M | Sell |
93,781
-3,287
| -3% | -$116K | 0.01% | 986 |
|
|
2022
Q4 | $4.45M | Sell |
97,068
-250
| -0.3% | -$11.5K | 0.01% | 844 |
|
|
2022
Q3 | $4.72M | Buy |
97,318
+13,168
| +16% | +$638K | 0.01% | 821 |
|
|
2022
Q2 | $3.31M | Buy |
84,150
+15,863
| +23% | +$623K | 0.01% | 972 |
|
|
2022
Q1 | $2.51M | Buy |
68,287
+22
| +0% | +$810 | ﹤0.01% | 1189 |
|
|
2021
Q4 | $3.11M | Buy |
68,265
+761
| +1% | +$34.7K | 0.01% | 1120 |
|
|
2021
Q3 | $2.41M | Buy |
67,504
+8,858
| +15% | +$317K | ﹤0.01% | 1230 |
|
|
2021
Q2 | $1.16M | Buy |
58,646
+231
| +0.4% | +$4.57K | ﹤0.01% | 1742 |
|
|
2021
Q1 | $1.36M | Sell |
58,415
-171
| -0.3% | -$3.98K | ﹤0.01% | 1672 |
|
|
2020
Q4 | $1.22M | Buy |
58,586
+124
| +0.2% | +$2.58K | ﹤0.01% | 1624 |
|
|
2020
Q3 | $1.27M | Buy |
58,462
+8,685
| +17% | +$188K | ﹤0.01% | 1433 |
|
|
2020
Q2 | $1.17M | Buy |
49,777
+261
| +0.5% | +$6.15K | ﹤0.01% | 1392 |
|
|
2020
Q1 | $584K | Buy |
49,516
+2,472
| +5% | +$29.2K | ﹤0.01% | 1626 |
|
|
2019
Q4 | $499K | Buy |
47,044
+685
| +1% | +$7.27K | ﹤0.01% | 1894 |
|
|
2019
Q3 | $528K | Buy |
46,359
+1,076
| +2% | +$12.3K | ﹤0.01% | 1806 |
|
|
2019
Q2 | $509K | Buy |
45,283
+3,480
| +8% | +$39.1K | ﹤0.01% | 1812 |
|
|
2019
Q1 | $338K | Buy |
41,803
+3,151
| +8% | +$25.5K | ﹤0.01% | 1965 |
|
|
2018
Q4 | $244K | Buy |
38,652
+3,127
| +9% | +$19.7K | ﹤0.01% | 1881 |
|
|
2018
Q3 | $350K | Buy |
35,525
+576
| +2% | +$5.68K | ﹤0.01% | 1823 |
|
|
2018
Q2 | $290K | Buy |
34,949
+2,043
| +6% | +$17K | ﹤0.01% | 1895 |
|
|
2018
Q1 | $237K | Buy |
32,906
+1,650
| +5% | +$11.9K | ﹤0.01% | 1918 |
|
|
2017
Q4 | $255K | Buy |
31,256
+616
| +2% | +$5.03K | ﹤0.01% | 1932 |
|
|
2017
Q3 | $444K | Buy |
30,640
+2,440
| +9% | +$35.4K | ﹤0.01% | 1634 |
|
|
2017
Q2 | $341K | Buy |
+28,200
| New | +$341K | ﹤0.01% | 1707 |
|